drugset / Trial / NCT00732654
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
Phase 1/2
Completed
30 enrolled
Johns Hopkins University
Duke University · collabGreer Laboratories · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if small oral and sublingual doses of milk protein are safe and effective in decreasing sensitivity to cow's milk in allergic children.
Timeline
- Start
- 2008-08
- Primary completion
- 2010-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Milk Powder | Unknown | 1000 mg | Oral |
| Subject | Milk Powder | Unknown | 2000 mg | Oral |
| Subject | Milk Protein Extract | Unknown | 4 mg | Subcutaneous |
| Subject | Milk Protein Extract | Unknown | 7 mg | Subcutaneous |